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Implications for Nursing Care 
Because there is no treatment for NAFLD, education plays a key role in the 
prevention and management of NAFLD in children, adolescents, and adults.  Both 
registered nurses (RN) and advanced practice nurses (APN) are valuable resources to 
provide education to patients and families to prevent further damage initiated by 
NAFLD. Important education topics include education about dietary changes, 
promotion of physical activity, and the importance of screening tests and imaging 
procedures. 
While some studies have examined specific nutrients to determine if certain foods 
place individuals at higher risk for NAFLD, Anderson et al. (2016) found that overall 
higher energy intake in childhood and early adolescents is associated with greater risk 
for NAFLD while the types of macronutrients are less important (p. 988). With this in 
mind, RNs and APNs should focus on moderation rather than restriction when 
providing education about healthy diets to their patients.  
Anderson et al. (2015) found increased exercise in in late childhood and lower fat 
mass in adolescence is linked to lower risk of ultrasound scan fatty liver and liver 
enzymes indicative of NAFLD (p. 116). In day-to-day clinical practice, RNs and APNs 
have valuable patient contact and are in pivotal roles to spend time educating their 
patients about lifestyle interventions including the importance of physical activity. Even 
if not the primary purpose of the contact, nurses should include questions about 
physical activity in their assessments. These questions allow nurses to determine 
where gaps exist and education about the importance of exercise may be beneficial in 
the prevention of NAFLD and many other chronic conditions. 
APNs should also be knowledgeable about basic screening, laboratory, and imaging 
procedures related to widespread metabolic conditions including NAFLD. By 
incorporating regular blood testing, including lipid profiles, glucose tests, and hepatic 
function panels in their assessments, APNs may be able to identify high-risk individuals 
and target specific interventions before the disease progresses. In addition, APNs 
should know that liver scans have proven reliable to assess the amount of liver damage 
in individuals; however, Anderson et al. (2016) found liver scans have proven more 
useful in the detection of moderate-severe hepatic steatosis and are less able to 
determine mild fat infiltration (p. 115).  This may lead to further progression of the 
disease if providers rely on this procedure for early detection. Liver biopsy has been 
identified as the “gold standard” to diagnose NAFLD (Berardis & Sokal, 2014, p. 134); 
however, it does impact individuals more significantly than less invasive procedures. 
Due to the risks for complications, biopsies should only be considered when absolutely 
necessary. 
Conclusion 
NAFLD is an often silent disease with serious health risks. If action is not taken to 
halt its pathologic processes, NAFLD may cause serious damage to the liver and other 
body systems. The importance of interventions related to energy intake and physical 
activity in obese children is well documented in the literature, citing the reduction of 
adipose tissue and the development of lean body mass as important processes to 
improve insulin sensitivity and decrease free fatty acids from entering the liver 
(Anderson et al., 2016, p. 111; Anderson et. al., 2015, p. 983) and ultimately leading to 
the development of NAFLD. By performing educational interventions in the form of 
promoting healthy diets and increased physical activity, RNs and APNs may be able to 
help children and adolescents decrease these risk factors, resulting in decreased 
incidence and/or progression of NAFLD and lead to better qualities of life long term.  
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Introduction 
Nonalcoholic fatty liver disease (NAFLD) is the most 
common chronic liver disease in the United States (McCance, 
Huether, Brashers, & Rote, 2014, p. 1461). Historically, NAFLD 
primarily affected adults; however, Berardis and Sokal (2014) 
identified NAFLD has also become the most common cause of 
chronic liver disease among children and adolescents in 
Western countries (p. 131). In association with rising rates of 
childhood obesity, the prevalence of children with NAFLD has 
more than doubled in the last two decades with the most recent 
estimate for NAFLD at 9.6% of the general pediatric population 
(Kohli et al., 2016, p. 9). While the disease process itself does 
not cause significant illness directly, children and adolescents 
with NAFLD are at much higher risk for serious chronic 
illnesses long term. 
 
Risk Factors 
The primary risk factor in the development of NAFLD is 
obesity, specifically increased levels of adipose tissue. Other 
risk factors include elevated triglyceride levels, elevated 
cholesterol levels, and insulin-resistance either with or without 
type 2 diabetes mellitus. 
 
Signs & Symptoms 
NAFLD is usually asymptomatic; however, certain 
individuals may experience: 
• Enlarged liver 
• Fatigue 
• Pain in the right upper abdominal quadrant (Mayo Clinic, 
2018) 
 
Changes at the Cellular Level 
NAFLD develops when liver cells become infiltrated with fat. 
Under the microscope, these hepatocytes contain visible 
amounts of fat within the cell membranes. Visible signs of 
inflammation may be present also if NAFLD has begun to 
progress to nonalcoholic steatohepatitis (NASH).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Comparison of normal and fatty liver cells.  From 
Nonalcoholic fatty liver disease by Mayo Clinic,  2018. Retrieved 
from https://www.mayoclinic.org/diseases-
conditions/nonalcoholic-fatty-liver-disease/symptoms-
causes/syc-20354567  
Underlying Pathophysiology 
In its healthy state, the liver is able to synthesize, catabolize, 
and store triglycerides and fatty acids (FFA) to be used as energy 
by the rest of the body. In moderation, the liver is able to break 
down triglycerides into glycerol and FFA and store any unneeded 
supplies until they are needed at a later time. However, if the liver 
is unable to process  excess quantities of these molecules, the 
surplus of triglycerides and/or FFAs are stored in hepatocytes as 
fat. The organelles in these cells become disrupted as large 
vacuoles of fat form within the cell membrane (McCance et al., 
2014).  
Causes of hepatic triglyceride accumulation include: increased 
delivery of free fatty acids to the liver, increased lipogenesis, and 
impaired fatty acid metabolism in hepatocytes (Berardis & Sokol, 
2014, p. 132). Increased delivery of FFAs may be the result of 
increased dietary intake or the release of FFAs from adipose cells.  
References 
American Cancer Society. (2018). Key 
Statistics About Liver Cancer. Retrieved 
from 
https://www.cancer.org/cancer/liver-
cancer/about/what-is-key-statistics.html 
Anderson, E.L., Fraser, A., Howe, L.D., 
Callaway, M.P., Sattar, N., Day, C., & ... 
Lawlor, D. A. (2016). Physical activity is 
prospectively associated with adolescent 
nonalcoholic fatty liver disease. Journal of 
Pediatric Gastroenterology & Nutrition, 
62, 110-117. 
doi:10.1097/MPG.0000000000000904 
Anderson, E.L., Howe, L.D., Fraser, A., 
Macdonald-Wallis, C., Callaway, M.P., 
Sattar, N., & ... Lawlor, D.A. (2015). 
Childhood energy intake is associated 
with nonalcoholic fatty liver disease in 
adolescents. Journal of Nutrition, 145, 
983-989. doi:10.3945/jn.114.208397 
Berardis, S., & Sokal, E. (2014). Pediatric non-
alcoholic fatty liver disease: An 
increasing public health issue. European 
Journal of Pediatrics, 173, 131-139. doi: 
10.1007/s00431-013-2157-6 
Farrell, G.C., van Rooyen, D., Gan, L., Chitturi, 
S. (2012). NASH is an inflammatory 
disorder: Pathogenic, prognostic and 
therapeutic implications. Gut and Liver, 6, 
149-171. doi: 10.5009/gnl.2012.6.2.149 
Kohli, R., Sunduram, S., Mouszaki, M., Ali, S., 
Sathya, P., Abrams, S., ...Schwimmer, J. 
(2016). Pediatric nonalcoholic fatty liver 
disease: A report from the expert 
committee on nonalcoholic fatty liver 
disease (ECON). The Journal of Pediatrics, 
172, 9-13. doi: 
10.1016/j.jpeds.2015.12.016 
Mayo Clinic. (2018). Nonalcoholic fatty liver 
disease. Retrieved from 
https://www.mayoclinic.org/diseases-
conditions/nonalcoholic-fatty-liver-
disease/symptoms-causes/syc-
20354567 
McCance, K. L., Huether, S. E., Brashers, V. L., 
& Rote, N. S. (2014). Pathophysiology: The 
Biologic Basis for Disease in Adults and 
Children. St. Louis, MO: Elsevier/Mosby.  
Additional Sources 
 Otterbein University, Westerville, Ohio  
Figure 2. Pathophysiology of nonalcoholic fatty liver disease. From 
“Mechanisms of Disease Progression in Nonalcoholic Fatty Liver 
Disease” by J. Jou, S.S. Choi, & A.M. Diehl, 2008, Seminars in Liver 
Disease, 28, 371. 
Significance of Pathophysiology 
As NAFLD is often asymptomatic, it can be present for years before it is detected.  This 
chronic, underlying condition has the potential to progress to serious, life-threatening 
illnesses.  If not addressed. NAFLD has the potential to progress to the following conditions: 
Nonalcoholic Steatohepatitis 
Nonalcoholic steatohepatits (NASH) occurs when hepatocytes become injured by stored 
fats and inflammatory processes take over leading to the recruitment cells in the innate 
immune system including: Toll-like receptors (TLRs), Kupffer cells (KCs), lymphocytes and 
neutrophils and possibly inflammasome (Farrell, van Rooyen, Gan, & Chitturi, 2012, p. 149). 
The effects of NASH are destruction of liver cells with possible progression to fibrosis which 
leads to decreased liver function. 
Cirrhosis 
If the inflammation and fibrosis continue, damage in the liver can progress to cirrhosis. 
Cirrhosis occurs when fibrous tissue replaces damaged hepatocytes, leading to further 
decrease in liver function. Cirrhosis is the twelfth leading cause of death in the United States 
and can lead to portal hypertension and jaundice (McCance et al., 2014, p. 1460).  
Liver Cancer 
Further damage to the liver can result in the formation of malignant neoplasms or 
hepatocellular carcinoma. Although cirrhosis is not a direct cause for all cases of liver 
cancer, it is a significant and preventable risk factor that leads to a potentially-fatal 
condition.  The American Cancer Society estimates ~42,000 individuals will be diagnosed 
with primary liver cancer in 2018 and of those individuals, ~30,000 will die from this 
illness (American Cancer Society, 2018).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Progression of liver damage. From Fatty liver disease by Fact Dr., 2018. Retrieved 
from https://factdr.com/health-conditions/fatty-liver-disease/ 
 
Damage to the liver may also result in disease processes in other body systems. Once the 
liver has become damaged, the affected individual is at risk for the following conditions: 
Insulin Resistance 
Increased levels of free fatty acids associated with NAFLD have been linked to the 
disruption of intracellular insulin signaling, decreased tissue responses to insulin, and 
alterations in insulin incretin and glucagon secretion (McCance et al., 2014, p. 739) placing 
these individuals at risk for the development of type 2 diabetes mellitus and its associated 
metabolic complications. 
Atherosclerosis 
Liver dysfunction and elevated levels of serum cholesterol levels as well as the release of 
inflammatory cytokines related to chronic inflammation are associated with endothelial 
damage that can lead to the formation of atherosclerotic plaques.  
Portal Hypertension  
Damage to the liver and its associated formation of scar tissue contribute to obstruction 
and remodeling of the portal venous system; this ultimately leads to portal hypertension 
and its associated complications which affect multiple body systems. Complications 
include: varices, splenomegaly, hepatopulmonary syndrome, ascites, and hepatic 
encephalopathy which may lead to fatal hemorrhage, thrombocytopenia, respiratory 
complications, electrolyte imbalances, infection, and mental status changes (McCance et al., 
2014, p. 1452-1454) 
Triglyceride accumulation occurs both in the liver as well as 
elsewhere in the body and contributes to the formation of 
adipocytes and adipose tissue. With increased adiposity comes a 
decreased level of serum adiponectin which increases hepatic 
glucogenesis and decreases skeletal muscle glucose uptake. This 
increase in levels of glucose as well as decrease in level of 
consumption contribute to further metabolic disruption and 
additional lipogenesis.  In addition to releasing FFAs, adipose 
tissue also releases a number of inflammatory markers including 
TNF-⍺ and IL-6 which contribute to further metabolic disruption 
(McCance et al., 2014).  
Figure 3. Fatty liver. “Liver and 
Biliary Disease.” (n.d.). 
Retrieved July 16, 2018  from 
http://www.pathguy.com/lect
ures/fatty_liver.jpg 
Fact Dr. (2018). Fatty  liver disease. 
Retrieved from 
https://factdr.com/health-
conditions/fatty-liver-disease/ 
Jou, J., Choi, S.S., & Diehl, A.M. (2008). 
Mechanisms of disease progression in 
nonalcoholic fatty liver disease. 
Seminars in Liver Disease, 28, 371.  
Liver and Biliary Disease. (n.d.). Retrieved 
from 
http://www.pathguy.com/lectures/fat
ty_liver.jpg 
 
